"MJNA" REPORTS NET 2016 REVENUE OF_$8,003,943!!!
EXCERPT FROM PR AS FOLLOWS:
SAN DIEGO, May 2, 2017 /PRNewswire/ -- Medical Marijuana, Inc. (OTC PINK: MJNA), the first-ever publicly traded cannabis company in the United States, today announced financial results for the quarter and year ending December 31, 2016, and provided an overview of recent operational highlights. The Company continued to show strong growth throughout the year, as 2016 revenue increased quarter over quarter by 66% from Q1 to Q4 and Net Comprehensive Income increased to $171,387,975 which is 731% higher than 2015. The company had net revenue of $8,003,943 in 2016
"As the No. 7 investor in Medical Marijuana, Inc., I'm proud to say we are on course for a historic 2017," Medical Marijuana, Inc. CEO Dr. Stuart Titus said. "From groundbreaking research conducted on the Company's products in Latin America during 2016, to substantial market cap growth by the Company's major investments and the development of new proprietary molecules and IP by portfolio companies, shareholders have a lot to be excited about."
Titus continued, "Medical Marijuana Inc. is a holding company with diversified assets that include nutraceutical sales divisions, as well as investments in early stage pharmaceutical development companies - all in the emerging cannabinoid space. We continue to believe in the future of the botanical as well as the pharmaceutical side - the growth in the Company's net assets in the past year only furthers our belief in our long term strategies to build shareholder value."
Medical Marijuana, Inc. had a positive year of growth in 2016, both with the Company's investments and wholly owned subsidiaries, including international expansion, new patent and trademark filings, sweeping new executive team appointments, new licensing agreements, and unprecedented developments in clinical research -- both for the Company's investment companies and flagship product Real Scientific Hemp Oil™ (RSHO™).